Literature DB >> 15748536

BENEDICT in the treatment of hypertension.

Alexander Logan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15748536     DOI: 10.1007/s11906-005-0085-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  13 in total

1.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

2.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

3.  Class differences in the effects of calcium channel blockers in the rat remnant kidney model.

Authors:  K A Griffin; M M Picken; G L Bakris; A K Bidani
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

4.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

5.  Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Authors:  R O Estacio; B W Jeffers; N Gifford; R W Schrier
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

6.  Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

Authors:  M Ravid; D Brosh; Z Levi; Y Bar-Dayan; D Ravid; R Rachmani
Journal:  Ann Intern Med       Date:  1998-06-15       Impact factor: 25.391

7.  Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.

Authors:  George L Bakris; Matthew R Weir; Shahnaz Shanifar; Zhongxin Zhang; Janice Douglas; David J van Dijk; Barry M Brenner
Journal:  Arch Intern Med       Date:  2003-07-14

8.  The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Authors:  Nadia A Khan; Finlay A McAlister; Norman R C Campbell; Ross D Feldman; Simon Rabkin; Jeff Mahon; Richard Lewanczuk; Kelly B Zarnke; Brenda Hemmelgarn; Marcel Lebel; Mitchell Levine; Carol Herbert
Journal:  Can J Cardiol       Date:  2004-01       Impact factor: 5.223

9.  Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

Authors:  G L Bakris; M R Weir; V DeQuattro; F G McMahon
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

10.  Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.

Authors:  Y Lacourcière; A Nadeau; L Poirier; G Tancrède
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

View more
  1 in total

Review 1.  Antihypertensive treatment for kidney transplant recipients.

Authors:  Nicholas B Cross; Angela C Webster; Philip Masson; Philip J O'Connell; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.